Hold Health Industry Observation | The food-medicine homology track welcomes a market exceeding 100 billion yuan; scientific and technological innovation becomes the key to breaking the deadlock

Recently, the National Health Commission and two other departments jointly released the "2024 Revision Plan for the Catalogue of Medicinal and Edible Products," adding nine substances, including Polygonatum and mulberry leaves. This marks a new stage of standardized development for China's medicinal and edible product industry. According to new data from the China Business Industry Research Institute, the market size of medicinal and edible products in China reached 185 billion yuan in 2023, a year-on-year increase of 23.7%, and is expected to exceed 250 billion yuan by 2025, becoming a rapidly growing segment of the larger health industry.

Continued policy benefits are driving industry transformation. The State Council's "Healthy China 2030" Planning Outline clearly lists "developing medicinal and edible functional products" as a key project, with special financial support increasing by 180% compared to 2020. Yang Longhui, vice president of the China Academy of Traditional Chinese Medicine, pointed out that "Modern pharmacology has verified the scientific value of 80% of traditional dietary supplements, providing theoretical support for industry upgrading." Currently, 14 national-level medicinal and edible raw material planting bases have been established nationwide. The annual output value of the Wenshan Sanqi base in Yunnan has exceeded 4.5 billion yuan, and has been featured in a Xinhua News Agency report.

Consumer trends show signs of becoming younger and more precise. JD Health's "2023 Annual Health Consumption Report" shows that the 18-35 age group accounts for 62% of the total consumption of medicinal and edible products, with innovative product categories such as ready-to-eat donkey-hide gelatin cakes and portable ginseng honey tablets experiencing a year-on-year growth rate of 137%. Research by the

Recently, the National Health Commission and two other departments jointly released the "2024 Revision Plan for the Catalogue of Medicinal and Edible Products," adding nine substances, including Polygonatum and mulberry leaves. This marks a new stage of standardized development for China's medicinal and edible product industry. According to new data from the China Business Industry Research Institute, the market size of medicinal and edible products in China reached 185 billion yuan in 2023, a year-on-year increase of 23.7%, and is expected to exceed 250 billion yuan by 2025, becoming a rapidly growing segment of the larger health industry.

Continued policy benefits are driving industry transformation. The State Council's "Healthy China 2030" Planning Outline clearly lists "developing medicinal and edible functional products" as a key project, with special financial support increasing by 180% compared to 2020. Yang Longhui, vice president of the China Academy of Traditional Chinese Medicine, pointed out that "Modern pharmacology has verified the scientific value of 80% of traditional dietary supplements, providing theoretical support for industry upgrading." Currently, 14 national-level medicinal and edible raw material planting bases have been established nationwide. The annual output value of the Wenshan Sanqi base in Yunnan has exceeded 4.5 billion yuan, and has been featured in a Xinhua News Agency report.

Consumer trends show signs of becoming younger and more precise. JD Health's "2023 Annual Health Consumption Report" shows that the 18-35 age group accounts for 62% of the total consumption of medicinal and edible products, with innovative product categories such as ready-to-eat donkey-hide gelatin cakes and portable ginseng honey tablets experiencing a year-on-year growth rate of 137%. Research by the Hold Health Research Institute found that 82% of consumers expect "visually demonstrable efficacy" products, prompting the group's R&D center to launch traceable goji berry products; scanning a QR code reveals dozens of data points, including the planting base and effective ingredient testing.

Industry regulation upgrades are giving rise to a new standard system. The "Identification Standards for Medicinal and Edible Products" newly implemented by the State Administration for Market Regulation requires all products to indicate the "recommended daily intake" and "suitable population." Data from the China Health Association shows that the market elimination rate exceeded 23% after the implementation of the new regulations, forcing enterprises to improve their R&D capabilities.

With the "14th Five-Year Plan for the Development of Traditional Chinese Medicine" including medicinal and edible products in the key projects of modernizing traditional Chinese medicine, the industry is transitioning from traditional tonics to precision nutrition upgrades. The Hold Health Group will continue to increase its efforts to promote the big health industry to enter a new era of "scientific dietary supplements".

(Data sources for this article: National Health Commission documents, China Business Industry Research Institute reports, JD Health consumer data, Xinhua News Agency reports)

Health Research Institute found that 82% of consumers expect "visually demonstrable efficacy" products, prompting the group's R&D center to launch traceable goji berry products; scanning a QR code reveals dozens of data points, including the planting base and effective ingredient testing.

Industry regulation upgrades are giving rise to a new standard system. The "Identification Standards for Medicinal and Edible Products" newly implemented by the State Administration for Market Regulation requires all products to indicate the "recommended daily intake" and "suitable population." Data from the China Health Association shows that the market elimination rate exceeded 23% after the implementation of the new regulations, forcing enterprises to improve their R&D capabilities.

With the "14th Five-Year Plan for the Development of Traditional Chinese Medicine" including medicinal and edible products in the key projects of modernizing traditional Chinese medicine, the industry is transitioning from traditional tonics to precision nutrition upgrades. The Hold Health Group will continue to increase its efforts to promote the big health industry to enter a new era of "scientific dietary supplements".

(Data sources for this article: National Health Commission documents, China Business Industry Research Institute reports, JD Health consumer data, Xinhua News Agency reports)